Luxa Biotechnology has presented clinical data from its Phase 1/2a trial evaluating RPESC-RPE-4W at ...

Lumata Health has raised $23 million in Series B funding, bringing its total funding to $36 million ...

Optos has announced the launch of MonacoPro, the next-generation ultra-widefield (UWF) SLO and spect...

Avirmax Biopharma has announced the initiation of Investigational New Drug (IND)-enabling studies fo...

Haag-Streit has officially launched the METIS 900, a cutting-edge ophthalmic surgical microscope des...

Adverum Biotechnologies has announced the initiation of the ARTEMIS phase 3 study, designed to evalu...

Nicox, a global ophthalmology company, presented new data on its intraocular pressure (IOP)-lowering...

Opthea has announced new findings from its phase 2b clinical trial evaluating sozinibercept for trea...

Altris AI has introduced its Advanced Optic Disc (OD) Analysis module to enhance glaucoma detection ...

Outlook Therapeutics has resubmitted its Biologics License Application (BLA) to the U.S. Food and Dr...